Welcome Back

Google icon Sign in with Google
OR
I agree to abide by Pharmadaily Terms of Service and its Privacy Policy

Create Account

Google icon Sign up with Google
OR
By signing up, you agree to our Terms of Service and Privacy Policy
Instagram
youtube
Facebook

Fsp Sr Cra I Oncology - Ny, Nj, Pa

3+ years
Not Disclosed
10 June 11, 2025
Job Description
Job Type: Full Time Education: B.Sc./M.Sc/B.Pharm/M.Pharm/Life Science Skills: Causality Assessment, Clinical SAS Programming, Communication Skills, CPC Certified, GCP guidelines, ICD-10 CM Codes, CPT-Codes, HCPCS Codes, ICD-10 CM, CPT, HCPCS Coding, ICH guidelines, ICSR Case Processing, Interpersonal Skill, Labelling Assessment, MedDRA Coding, Medical Billing, Medical Coding, Medical Terminology, Narrative Writing, Research & Development, Technical Skill, Triage of ICSRs, WHO DD Coding

 

Job Title:

FSP Senior CRA I – Oncology (Remote) | New York, New Jersey, Pennsylvania


Job Summary:

Fortrea, a global leader in Contract Research services, is seeking an experienced Senior Clinical Research Associate (CRA) I to join its Functional Service Provider (FSP) team. This remote position is open to candidates based in New York, New Jersey, or Pennsylvania with a strong background in oncology and CNS clinical trials. The role demands over 3 years of clinical monitoring expertise and offers the opportunity to lead site management activities, ensure protocol adherence, and contribute to global drug development initiatives.


Key Responsibilities:

  • Oversee all aspects of study site monitoring, including routine visits, initiation, and close-out of clinical sites.

  • Maintain and manage comprehensive study files as per project plans.

  • Ensure that clinical staff at study sites are well-trained and equipped for protocol compliance.

  • Safeguard patient rights by verifying adherence to informed consent procedures and regulatory standards.

  • Conduct source data verification to ensure data accuracy, completeness, and integrity.

  • Perform registry management and feasibility assessments as assigned.

  • Handle Serious Adverse Event (SAE) documentation and reporting, including narrative preparation and follow-up.

  • Independently review Case Report Forms (CRFs) and resolve queries per data management guidelines.

  • Mentor and co-monitor with junior CRAs or new hires.

  • Act as a Local Project Coordinator or client contact, where applicable.

  • Adapt quickly to evolving project needs in a high-paced, technology-driven environment.


Required Skills & Qualifications:

  • University degree or certification in a healthcare-related field (e.g., Nursing).

  • Minimum 3 years of Clinical Monitoring experience.

  • Prior experience in Oncology and/or CNS trials preferred.

  • Familiarity with regulatory requirements and GCP guidelines.

  • Strong data review and query resolution skills.

  • Ability to manage shifting priorities and tight timelines.

  • Excellent teamwork, communication, and problem-solving abilities.

  • Comfortable working in fully electronic clinical environments.


Perks & Benefits:

  • Competitive salary: Target range $115,000–$120,000 annually.

  • Comprehensive benefits: Medical, Dental, Vision, Life, Short/Long Term Disability insurance.

  • 401(K) retirement savings plan.

  • Paid Time Off (PTO) under the Flex Plan.

  • Employee Recognition Programs and Awards.

  • Participation in Employee Resource Groups (ERGs).

  • Remote work flexibility.


Company Description:

Fortrea is a global Contract Research Organization (CRO) specializing in clinical development solutions across over 20 therapeutic areas. With operations in nearly 100 countries, Fortrea partners with pharmaceutical, biotechnology, and medical device clients to drive innovation and improve patient outcomes worldwide.


Work Mode:

Remote – Open to candidates residing in New York, New Jersey, or Pennsylvania


Call to Action:

Ready to shape the future of oncology clinical trials? Apply now to join Fortrea as a Senior CRA I and play a critical role in delivering life-changing therapies to patients globally.